Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

156 primary * profile

12th World AIDS Conference

SKeyword

Abstra

ts to improve access to and secondary HIV prevention/A
exual risk-taking with and non-primary partners/HIV+
fected persons at initial care presentation and six months I
d management into the health care system/Integration of
family/Mothers role as providers of sexual education with
nges in the tonsil during HIV infection/Evidence of histolo
ation in acutely infected Th2 cells and cell lines/Triggering
n of human cervix with a isolate HIV-1 subtype E/Infection
on-induced cell death in acute infection/Expression of mol
esion molecules during HIV-1 infection. Relationship with
Potent neutralization of HIV-1 isolates by antisera induce
ycoproteins from either isolates or T-cell lines adapted str
cytokine production in human T cells/Effect of a gpl20-d
nts and compliance to prophylaxis therapy to tuberculosi
sing out?/Underuse of prophylaxis for Mycobacterium av
00/L/Withdrawal of prophylaxis against P. carinii and
mens?/ls it safe to stop PCP prophylaxis in patients treate
one-pyrimethamine for prophylaxis of P. carinii pneumoni
linic attenders at five health care centres in Nairobi, Ke
ECT in the diagnosis of central nervous system lymphom
F) as predictive value of cerebral lymphoma HIV-related:
ng tritherapy initiated at HIV-1 infection/Full compliance s
patients after linkage to care/Evolution of depressive sym
ed infection with HIV-1 isolates in the hu-PBL-SCID mou
spect to the infection of macrophages with autologous vir
tibodies against HIV-1 isolates positively correlate with C
ra able to neutralize 17 HIV-1 isolates belonging to group
troviral therapy during HIV infection is associated with ra
h HAART/Discontinue prophylaxis regimens in selected
als induce apoptosis of neurons/Inflammatory cytokines
iants in individuals with HIV-1 infection/Frequency of tran
man: The UCSF options HIV project/Transmission of prote
ance testing (GART) in care settings in Atlanta, Georgia/
age solutions between care, HIV/AIDS, substance abuse
ive HIV prevention and care in methadone and other drug
D case management in health care facilities in Uganda/B
and integration with the health care services in Banglades
ng and counselling at a care health center in a poor neigh
he French press?/How AIDS prevention is covered by the
educator programme in schools in Tanzania/Developmen
p model to link HIV and health and supportive care servic
elective transduction of human CD4+ T-cells/Effective ps
y for diagnosis of acute HIV infection and estimation of HI
es the detection rate of HIV infection/Screening with com
Worldwide education of care providers: New antiretroviral
for the provision of HIV care to persons otherwise lost to f
epicenter/Evolution of health care concepts in communit
th period/Retention in health care of clients diagnosed w
orative approach to HIV care education in smaller centres
nt: Planned changes in health care by Ryan White CARE
A medical record for HIV care/A medical record for HIV
f STD/AIDS services to health care: A community based a
S prevention proyect in care attention/Strategies and ach
D/HIV in the community/ health care settings/Prevention a
ving with AIDS And HIV prevention/People living with AID
/Cost-effectiveness of HIV-prevention -A systematic rev
STD/AIDS prevention in health care setting in redlight distri
nd Chlamydia in an MV care population/Urine-based scre
with HIV-1 symptomatic infection on antiretroviral tritherap
care of HIV+ women at care services, a study and propos
ells with different HIV-1 isolates/Infection of dendritic cell
seful in the diagnosis of CNS lymphoma in HIV patients?/
usions/HIV-associated malignant lymphomatous effusion
s/Coreceptor usage by HIV-2 isolates/Coreceptor usage
solates/Multitropism of HIV-1 isolates/Multitropism of
ent: How to distinguish primo-infected from old infected patients
since 1996-1997/The PRIMO cohort: Preliminary results from 55
Hepatitis Prevention in Prison /HIV risk behaviours and HIV serop
ment/HOPE worldwide Program: Support and prevention b
sitive and seronegative prison inmates in Lagos, Nigeria/Initial dr
d HIV infections among inmates in Lagos, Nigeria/Pulmon
uberculosis and AIDS in /Tuberculosis and AIDS in
y STD/AIDS program in in Senegal?/Which policy STD/AID

g New York State (NYS) entrants, 1987-1997/Trends in HI
HCV inside a Canadian /A look behind closed doors: Injecti
on of the inmates of the system of Rio de Janeiro/Health ev
m HIV infection/AIDS in s - The history of life in prison as an
ence of HIV infection in system of Rio de Janeiro, Brazil -1
and seropositivity in the system of Rio de Janeiro, Brazil/Ri
nsmission in an African /A longitudinal study of the risk of HI,ct
13586
14176
14178
14293
14335
21128
21153
21155
21161
21173
550*/21194
21207
21212
22156
22167
22179
22180
22181
22190
22291
22324
22384
24231
330*/31103
31105
31109
31113
109*/31121
31225
32200
228*/32280
32288
32291
32410
32421
33229
33251
33330
33476
33522
34209
41245
42105
42109
42231
42312
72*/42398
42402
42409
42415
42421
43180
43190
43199
43206
43220
43348
60296
60316
60327
60404
60496
60506
60683
60684
41110
12187
23527
43307
13255
13256
22136
23511

23516
23528
23537
23555
23563
23568
23589

Keyword

Abstr

al drug consumption in system of Rio de Janeiro, Brazil/ST
nsitization workshop for workers in Brazil/Death: A sensitiz
IV infection and AIDS in: Prevalence surveys/HIV infection
vention work by NGO in settings in St. Petersburg region/P
DS/STDs education for communities in Lagos State, Nigeri
r of inmates in a French: Analysis by number of incarceratio
distribution in the Swiss setting: A breakthrough?/Needle di
ate visit program on the system of Rio de Janeiro/STD/AID
and HIV infections in a in the French part of Switzerland: A
y peers in the African system: The example of the C6te d'
r health aspects for the system of Rio de Janeiro/Specific i
V prevention policies in /HIV prevention policies in
Treatment education in: Facing the challenges of a controll
on controlled in a Swiss for women over two years/HIV- an
g drug in treatment and prisoners in Tijuana, Baja California, Mexi
sociated risk factors in in England and Wales in 1997:
ence among European: A multicenter study of the EC N
vulnerability of women to HIV/AIDS at the state peniten
d syphilis among female in Brazil/Seroprevalence of HIV
sing of HIV infection in a population, Senegal/Evidence f
DS transmission among in the State of Sao Paulo, Brazil
Argentina/HIV/AIDS in of the States of Santa Fe, Argen
mission among Arabian of northern Italy using peer educ
Promoting the rights of:Condoms, bleach, needles, me
duction peer project for /Harm reduction peer project for
f the STD/HIV/AIDS for of Dominican Republic/Prevent
ilis among the addicted /The simultanity of HIV, and HB
e in female HIV infected of Rio de Janeiro, Brazil/Study

act23592
24253
32435
33203
43197
43402
43403
43407
43411
43412
43416
44196
44198
60493
23218
23510
23527
23543
23574
23575
23588
32434
33560
537*/44191
44195
60755
60835
60903

V treatment adherence/ Prisons and public health: Emerging issue 501*/32408
haviour in nine Swedish prisons /Low HIV seroprevalence in spite 23552
m HIV infection/AIDS in -The history of life in prison as an 23555
patitis and STDs in gate of Rio de Janeiro (1996/1997)/Co 23562
education in two major in Nigeria/Comparative study of s 23586
g HIV/AIDS/STD in the in Kathmandu, Nepal/Challenge i 33586
n programs in Brazilian /HIV prevention programs in Brazi 43410
red inmates in 4 French /AIDS support program targeting t 43418
methadone and care in /Promoting the rights of prisoners: 537*/44191
s: Situation in European /Management of HIV/AIDS relate 44193
/AIDS control in African /Problems of HIV/AIDS control in 60036
HIV/AIDS education for /Preventive HIV/AIDS education f 60100
AIDS/The dilemmas of privacy and confidentiality in the preventio 44190

grams in the workplace/ Private sector involvement in sustainable
DS prevention in Siaya/ sector integration in AIDS preventi
mit HIV +ve patients by private nursing homes: A help based progr
seropositive patients in hospitals in Nairobi, Kenya/Opport
e by the personnel of a enterprise. An example of the C6te
es (STD) quality care to medical practitioners in Tamil Nad
elling clinic outreach to medical centres: The Nigerian exp
D patients in unlicensed clinics in China/The health seekin
ical practices: A public- partnership with worldwide internet
tcomes after HAART in practice/Clinical and virologic outc
TD management in the sector in Osun State, Nigeria/STD
IDS information flow in health services in the State of Sdo
f marginalized groups/ Privatization of health care services in Mal
w income populations/ Privatizing Medicaid: The implications for
HIV activity/Oral PMPA pro-drug: Relationship between clinical ph
nopurine dioxolane is a of dioxolane guanosine a novel i
stance in HIV infection/ Pro-inflammatory cytokines and insulin re
ppressive and reduced pro-inflammatory activity/Generation of r
tients/Plasma levels of cytokines after pneumo
ed disease pathogens/ PRO 2000 gel, a potential topical microbici
n HIV-infected children/ Probabilistic forecasting of AIDS onset in
-progressors (LTNPs)/ Probability of progression and predictivity
n a population-based probability sample of Dar es Salaam, Tan
n a population-based sample of North and Central Tr
ng a household-based sample of men who have sex
iral medication use in a sample of HIV seropositive MS
al model to estimate the of being infected by HIV/Math
ations in HIV-1 RT/Line Probe assay compared with clonal and po
Assessment of the Line assay in the detection of nucleoside
ded, subgenomic DNA probes /Fluorescent in situ hybridization to
all service demand and profilatic strategy propositions/Profile of t
/The 24-Hour hormonal profile in HIV-Infected children/The 24-Ho
nd pharmacokinetics of (+)-calanolide A -a naturally occ
actions and resistance of the nonnucleoside RT inhibitor (+
am experience/Safety of Viracept in the treatment of HIV p
Bombay, India/Clinical of 1800 HIV/AIDS patients at the on
Brazil, 1995-1996/The of AIDS in-patient care covered by
razil/Social-behaviour of HIV infected women from Rio de
of CMV retinitis/Safety of low (3.0 mg/ml) and high (6.6 mg/

13446
60027
12425
13244
13466
13475
13479
24167
42292
42422
60260
60974
60105
60339
12211
12358
32276
11101
60488
33146
60695
13351
13116
13165
24172
33169
60197
41219
41220
41159
60911
12176
12216
12366
12393
71 */12409
12429
14355
22245